Melanoma: open trials in Denmark

23 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Rigshospitalet, Copenhagen Oe
Registry updated 2026-11-03
NCT07694414
Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events
Trial Treatment · Phase 1 · Inge Marie Svane
National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev
Registry updated 2026-10-20
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N
Registry updated 2026-10-06
NCT04752826
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Trial Treatment · Phase 1/2 · BioInvent International AB
Rigshospitalet, Copenhagen · Herlev Hospital, Herlev
Registry updated 2026-09-18
NCT04855435
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
Trial Treatment · Phase 1 · MonTa Biosciences ApS
Herlev and Gentofte Hospital, Center for Cancer Research, Herlev
Registry updated 2026-08-10
2022-502633-26-00
Does peri-operative treatment with Tranexamic Acid reduce the early relapse rate for patients with melanoma; a randomised controlled trial
Trial Treatment · Phase 3 · Aarhus University Hospital
Aalborg University Hospital, Aalborg · Aarhus University Hospital, Aarhus N · Rigshospitalet, Copenhagen Oe · Herlev Hospital, Herlev · Odense University Hospital, Odense C · Zealand University Hospital, Roskilde · Lillebaelt Hospital, Vejle
Registry updated 2026-07-28
2023-506400-99-00
Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
Trial Treatment · Phase 2 · Vall D Hebron Institute Of Oncology
Herlev Hospital, Herlev
Registry updated 2026-07-23
NCT07501117
Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
Trial Treatment · Phase 1 · Inge Marie Svane
National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev
Registry updated 2026-07-01
NCT07015190
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Trial Treatment · Phase 3 · IDEAYA Biosciences
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe
Registry updated 2026-05-06
NCT06112314
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Trial Treatment · Phase 3 · Immunocore Ltd
Kobenhavns Universitet - Herlev Hospital (Amtssygehuset i Herlev), Herlev
Registry updated 2026-02-25
2025-524953-15-00
Neoadjuvant nivolumab and ipilimumab for patients with high-risk uveal melanoma
Trial Treatment · Phase 1 · Region Hovedstaden
Herlev Hospital, Herlev
Registry updated 2026-02-04
NCT07347392
The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.
Research · University of Aarhus
Aarhus University Hospital, Aarhus N
Registry updated 2026-01-16
NCT06206707
FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis
Trial Treatment · University of Aarhus
Aarhus University Hospital, Aarhus N
Registry updated 2025-11-17
NCT07215182
[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Trial Treatment · Phase 2 · Barbara Malene Fischer
Rigshospitalet, Copenhagen Oe · Herlev Hospital, Herlev
Registry updated 2025-10-10
NCT06204991
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
Trial Treatment · Phase 1 · Inge Marie Svane
Department of Oncology, Herlev
Registry updated 2025-08-24
NCT05899465
Perioperative Treatment With Tranexamic Acid in Melanoma
Trial Treatment · Phase 3 · University of Aarhus
Aalborg University Hospital. Dept. of Plastic- and Breast Surgery., Aalborg · Aarhus University Hospital. Dept. of Plastic- and Breast Surgery, Aarhus · Copgenhagen University Hospital, Rigshospitalet. Dept. of Plastic Surgery and Burns Treatment, Copenhagen · Copenhagen University Hospital, Herlev. Dept. of Plastic Surgery, Herlev · Sygehus Lillebælt, Vejle Hospital. Dept. of Plastic Surgery, Vejle
Registry updated 2025-03-18
NCT06783270
T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma
Trial Treatment · Phase 1 · Inge Marie Svane
Herlev Hospital, Herlev
Registry updated 2025-01-20
2024-519066-49-01
Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma
Trial Treatment · Phase 4 · Region Hovedstaden
Region Hovedstaden, Herlev
Registry updated 2024-12-16
NCT06685562
The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
Research · Leiden University Medical Center
Sygehus Lillebaelt, Vejle
Registry updated 2024-11-12
2023-509665-20-00
ADP-TILIL7
Trial Treatment · Phase 1 · Herlev Hospital
Herlev Hospital, Herlev
Registry updated 2024-06-25
NCT05280314
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
Trial Treatment · Phase 2 · IO Biotech
Aarhus University Hospital, Aarhus · Copenhagen University Hospital - Herlev, Copenhagen
Registry updated 2024-03-18
NCT03563729
Melanoma Metastasized to the Brain and Steroids
Trial Treatment · Phase 2 · Inge Marie Svane
Aarhus Universitet, Aarhus N · Region Hovedstaden, Herlev · Odense University Hospital, Odense C
Registry updated 2023-07-13
NCT05253872
The MELAcare Study: A New Method for Surveillance of Melanoma Patients
Trial Treatment · Herlev and Gentofte Hospital
Herlev and Gentofte Hospital, Copenhagen
Registry updated 2023-06-26

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error